AI-curated news about real-world psychedelic research, policy, and developments
Mesa isn’t a small suburb tucked behind Phoenix. It’s the third largest city in Arizona, with a police department that employs more than 800 sworn officers, a fire and medical department that’s been in operation since 1898 and an aerospace and defense corrido…
This post suggests how to use the client's emerging imagery, memories, and unconscious content during a psychedelic session to move toward therapy goals.
Today’s psychedelics bear little resemblance to 1970s counterparts. These medicines undergo rigorous clinical trials and licensed manufacturing processes.
Using simultaneous PET–MRI, McCulloch, Larsen and colleagues quantify LSD’s dose–occupancy relationship at the serotonin 2A receptor and reveal hemodynamic effects of LSD that contrast with those of psilocybin.
We’re seeing what happens when consumer demand collides with commercial interests for drugs including GLP-1s, psychedelics and testosterone. It’s a huge shift.
Most veterans in a small Stanford ibogaine study kept their PTSD gains at 12 months, but the study had no control group, and heart risks remain.
New animal research suggests the injured brain may respond favorably to injection of psilocybin.
Government-backed research into next-generation psychedelics and neuroplastogens for addictive disorders underscores the continued momentum behind this promising drug class. TAMPA, Fla., Oct. 8, 2026 /PRNewswire/ -- Psilera Inc. ("Psilera"), a leading biophar…
NEW YORK and TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) — Helus Pharma Inc. (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is …
From psychiatric research to counterculture and secret CIA mind-control experiments, LSD makes its way back to the lab.
VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (FSE: 8BN) (“Optimi” or “the Company”), a commercial-stage pharmaceutical manufacturer and clinical-stage developer of regulated psychedelic drug prod…
All-share transaction: Recognify shareholders – including atai Life Sciences, Catalio Capital Management and Sudhoff Family Office – become shareholders of AmyriAD RL-007 adds a differentiated clinical-stage cognition program in Cognitive Impairment Associate…
FDA wants ibogaine trials run in inpatient units with continuous heart monitoring because the unapproved drug can trigger dangerous heart rhythms.
From ayahuasca for mental health to poo transplants for gut health, Judith Lucy has been on a mission to feel better, but have they worked? Judith is one of Australia's most loved comedians. She's also the author of four books and the presenter of several …
An LSD trip can be sublime and life-changing; it can also be terrifying.
The U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and seeking public input on those approaches.
Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade ibogaine as TIRC advances its planned U.S. development program HIGHLIGHTS Texas Ibogaine Research Corporation (“TIRC”), the wholly-owned Texas subsidiary of Psyence…
Received single high dose of psilocybin-containing mushrooms
Psychedelics show promise for depression and anxiety. Federal support is growing, but drugs are advancing at different speeds. Hope needs evidence of benefit and safety.
‘Session Games People Play' was one of the first pamphlets for taking hallucinogens. The post LSD guide from 1967 still has good advice, psychologists say appeared first on Popular Science.
The four-year partnership integrates ongoing psychiatric care with specialized IV ketamine treatment, creating a more efficient and coordinated care pathway for patients with depression. NEW YORK, Sept. 30, 2026 /PRNewswire/ -- Lavender Psychiatry, the larges…
What Drug Do You Get From Frogs? A Deep Dive into Bufo Alvarius The potent psychedelic drug 5-MeO-DMT, derived from the venom of the Sonoran Desert Toad (Bufo alvarius), is the most well-known substance harvested from frogs, used historically in shamanic ritu…
Could hallucinogenic drugs become part of mainstream NHS care to treat depression?
Feminists on the internet are erupting in rage and recognition after a former Cornell University student filed a lawsuit alleging she was pressured to take ketamine and was subsequently gang-raped for seven hours at a Cornell fraternity house. At the same tim…
Binding term sheet with PsyLabs provides Psyence BioMed’s Texas subsidiary with exclusive U.S. development, supply and distribution rights to PsyLabs’ pharmaceutical-grade ibogaine, subject to a definitive agreement NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) —…
Carilion Clinic won a $623,000 federal grant for an early psilocybin study in cocaine addiction. The treatment remains experimental.
One cGMP batch, manufactured in-house under Optimi's Health Canada Drug Establishment Licence, supplies both the Canadian trial and Australian clinics
Non-prescribed ketamine use may start at the age of 13, suggest data from a UK clinic dedicated to the treatment of bladder problems associated with misuse of the drug and published in a clinical letter in the Archives of Disease in Childhood.
Trauma-informed care with psychedelics involves enhancing agency, maintaining relational safety, prioritizing consent, and providing corrective opportunities for past trauma.
TORONTO, Sept. 22, 2026 (GLOBE NEWSWIRE) — Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is pleased to announ…
Reading Time: 2 minutesPresley's addiction treatment program reportedly included ketamine therapy. Presley Gerber Was Treated With Ketamine at Rehab Center Despite Past Ketamine Addiction: … was originally published on The Hollywood Gossip.
People who were in regular contact with Presley Gerber say a doctor prescribed him ketamine even though the doctor knew about his addiction and his recurring problems with the drug. According to TM…
Psilocybin could be an unexpected avenue for treating an injury that currently has few options beyond rest and symptom management.
NIH awarded $2.3 million for a Boston ibogaine study in opioid use disorder, with heart rhythm limits built in. What families should know first.
Cybin (NASDAQ:HELP), doing business as Helus Pharma, held its Annual General and Special Meeting of Shareholders, where shareholders were asked to consider r...
CEO Michael Halstead to participate in a fireside chat on September 23, 2026 at 9:00 a.m. EDT NEW YORK and TORONTO, Sept. 21, 2026 (GLOBE NEWSWIRE) — Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutica…
Psychedelic have never been bigger. People are taking hallucinogens not for fun, but to find a deeper spiritual connection with the divine
Poster presentations further characterize clinical profile of HLP003 and Phase 3 PARADIGM program evaluating HLP003 as a potential adjunctive treatmentfor major depressive disorder (“MDD”) NEW YORK and TORONTO, Sept. 21, 2026 (GLOBE NEWSWIRE) — Helus Pharma …
Definium Therapeutics, Inc. (NASDAQ:DFTX) has now delivered a third consecutive positive Phase 3 readout for its LSD-based medication, the second in generalized anxiety disorder. The result puts the company on a viable route toward a potential FDA approval of…
Ketamine and Psychedelic Medicines Breakthroughs for Mental Health Challenges. from Depression, Anxiety to PTSDsubstack.com
TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its La…
This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) announced plans to initiate a Health Canada-authorized Phase 3 clinical trial in 2027 evaluating MDMA-ass…
